Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost layer of the intestinal lining. Ulcerative colitis is a chronic, incurable disease with low mortality that is generally diagnosed in adolescence and early adulthood.
Ulcerative colitis is currently an idiopathic condition, the pathogenesis of which is yet to be fully elucidated. However, it is known to involve an interaction between genetics, the immune system, and environmental factors. Risk factors include ethnicity, family history, antibiotic or non-steroidal anti-inflammatory agent use, and diet. Incidence and prevalence have been increasing over the past two decades in most regions of the world.
Datamonitor Healthcare estimates that in 2015, there were 2.1 million diagnosed prevalent cases of ulcerative colitis in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK). Over 2015–35, the number of prevalent cases is expected to increase to 2.5 million (16.6% increase).
Our reports have been used by over 10K customers, including:
Vitiligo - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Pipeline Review, H1 2020, provides an overview of the Vitiligo (Dermatology) pipeline landscape. Vitiligo is a condition in which skin loses melanin, the pigment that determines...
Cathepsin S - Pipeline Review, H1 2020 Summary According to the recently published report ’Cathepsin S - Pipeline Review, H1 2020’; Cathepsin S (CTSS or EC 18.104.22.168) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.